Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Matrix Biol ; 18(4): 331-41, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10517180

ABSTRACT

To determine whether the collagen network is compromised by collagenase during acute inflammation, a monoclonal antibody (9A4) was developed with specificity for the C-terminal neoepitope sequence generated by collagenase-cleavage of type II collagen (Gly-Pro-Pro-Gly-Pro-Gln-Gly-COOH). 9A4 was shown to detect the collagen collagenase-cleavage neoepitope with a K = 1.7 x 10(-7) M (type II) and K = 2 x 10(-6) M (type I). It does not recognize uncleaved native or denatured collagen. Articular cartilage from control animals is unstained by 9A4. During acute inflammation elicited in hamsters by intra-articular LPS, positive staining for the 9A4 neoepitope indicated the collagen was damaged. Wheel running exercise was used to apply stress to control cartilage and cartilage from animals with damaged collagen. After 6 months of running, the cartilage from normal animals was unaffected. By contrast, in the group with damaged collagen, the cartilage was fibrillated in all animals and in half of those, the cartilage failed and bony eburnation resulted.


Subject(s)
Antibodies, Monoclonal , Collagen/metabolism , Collagenases/metabolism , Acute Disease , Animals , Antibodies, Monoclonal/biosynthesis , Antibody Specificity , Cartilage, Articular/immunology , Cartilage, Articular/pathology , Collagen/chemistry , Collagen/immunology , Cricetinae , Epitopes , Female , Immunohistochemistry , Lipopolysaccharides , Mesocricetus , Mice , Mice, Inbred BALB C , Microscopy, Electron , Osteochondritis/chemically induced , Osteochondritis/immunology , Osteochondritis/metabolism , Osteochondritis/pathology , Physical Exertion , Surface Plasmon Resonance
2.
J Pharmacol Exp Ther ; 285(3): 946-54, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9618393

ABSTRACT

CP-195543 [(+)-2-(3-benzyl-4-hydroxy-chroman-7-yl)-4-trifluoromethyl-benzoic acid] is a structurally novel, selective and potent leukotriene B4 (LTB4) receptor antagonist. In vitro CP-195543 inhibited [3H]LTB4 binding to high-affinity LTB4 receptors on human neutrophils (HN) and murine spleen membranes with IC50 values of 6.8 nM (Ki = 4.9 nM) and 37.0 nM (Ki = 26.9 nM), respectively. CP-195543 inhibited human and mouse neutrophil chemotaxis mediated by LTB4 with IC50 values of 2.4 nM and 7.5 nM, respectively. Evidence of noncompetitive antagonist effects on the HN high-affinity LTB4 receptor was obtained by Scatchard analysis of [3H]LTB4 binding to and chemotaxis of HN to LTB4. Scatchard analyses of [3H]LTB4 binding to low-affinity receptors on HN indicated that CP-195543 acted as a competitive antagonist at this receptor, and inhibition of LTB4-mediated CD11b up-regulation on HN was inhibited competitively by CP-195543 (pA2 = 7.66). In whole blood, CP-195543 also blocked CD11b up-regulation on HN (pA2 = 7.12) and murine neutrophils (pA2 = 7.06) with a similar potency. LTB4-mediated CD11b up-regulation on human monocytes and eosinophils in whole blood were inhibited by CP-195543 with IC50 values of 270 nM and 420 nM, respectively. CP-195543 at 10 microM failed to inhibit HN chemotaxis and CD11b up-regulation mediated through alternative (i.e., complement fragment 5a, interleukin-8, platelet-activating factor) G-protein-coupled chemotactic factor receptors. In vivo, after oral administration, CP-195543 blocked LTB4-mediated neutrophil infiltration in guinea pig and murine skin with ED50 values of 0.1 mg/kg and 2.8 mg/kg p.o., respectively. When administered in osmotic pumps, CP-195543 reduced the clinical symptoms and attendant weight loss in an IL-1-exacerbated murine model of collagen-induced arthritis with half-maximal effects associated with plasma drug levels of 0.4 to 0.5 microg/ml. Collectively these data provide evidence of the in vitro potency and in vivo efficacy of a novel LTB4 antagonist and support its clinical evaluation in a variety of inflammatory diseases in man.


Subject(s)
Chromans/pharmacology , Leukotriene B4/antagonists & inhibitors , Neutrophils/drug effects , Animals , Arthritis/chemically induced , Arthritis/prevention & control , Cell Adhesion Molecules/drug effects , Cell Adhesion Molecules/metabolism , Chemotactic Factors/metabolism , Chemotaxis/drug effects , Chromans/chemistry , Collagen , Drug Evaluation, Preclinical , Humans , Interleukin-1/metabolism , Macrophage-1 Antigen/drug effects , Mice , Mice, Inbred BALB C , Monocytes/drug effects , Monocytes/metabolism , Neutrophils/physiology , Prostaglandins/biosynthesis , Spleen/drug effects , Spleen/metabolism , Zymosan/adverse effects
3.
J Exp Med ; 185(6): 1123-9, 1997 Mar 17.
Article in English | MEDLINE | ID: mdl-9091585

ABSTRACT

Collagen-induced arthritis in the DBA/1 mouse is an experimental model of human rheumatoid arthritis. To examine the role of leukotrienes in the pathogenesis of this disease, we have developed embryonic stem (ES) cells from this mouse strain. Here, we report that DBA/1 mice made deficient in 5-lipoxygenase-activating protein (FLAP) by gene targeting in ES cells develop and grow normally. Zymosan-stimulated leukotriene production in the peritoneal cavity of these mice is undetectable, whereas they produce substantial amounts of prostaglandins. The inflammatory response to zymosan is reduced in FLAP-deficient mice. The severity of collagen-induced arthritis in the FLAP-deficient mice was substantially reduced when compared with wild-type or heterozygous animals. This was not due to an immunosuppressive effect, because anti-collagen antibody levels were similar in wild-type and FLAP-deficient mice. These data demonstrate that leukotrienes play an essential role in both the acute and chronic inflammatory response in mice.


Subject(s)
Arthritis, Experimental/physiopathology , Carrier Proteins/metabolism , Carrier Proteins/physiology , Collagen/immunology , Membrane Proteins/deficiency , Membrane Proteins/metabolism , Membrane Proteins/physiology , 5-Lipoxygenase-Activating Proteins , Animals , Antibody Formation , Arthritis, Experimental/pathology , Arthritis, Experimental/prevention & control , Blood Proteins/metabolism , Female , Heterozygote , Humans , Joints/immunology , Joints/pathology , Leukotrienes/biosynthesis , Leukotrienes/physiology , Male , Mice , Mice, Inbred DBA , Mice, Knockout , Peritoneal Cavity , Stem Cells , Zymosan/pharmacology
4.
J Exp Med ; 183(4): 1893-8, 1996 Apr 01.
Article in English | MEDLINE | ID: mdl-8666945

ABSTRACT

Leukotriene B4 (LTB4) is a chemotactic and cell-activating factor present at inflammatory sites in a variety of autoimmune diseases including multiple sclerosis (MS). In this study, we used a murine model of MS, experimental allergic encephalomyelitis (EAE), to assess the potential role of LTB4 on cell infiltration and paralysis. Injection of encephalogenic T cells into naive animals induced paralysis and weight loss that was completely inhibited by treatment with the selective LTB4 receptor antagonist CP-105,696 (ED50= 8.6 mg/kg orally). Although migration of lymphocytes into the central nervous system was unaffected, the efficacious effects of CP-105,696 correlated with up to a 97% decrease in eosinophil infiltration into the lower spinal cord as determined by light and electron microscopy and quantitated by levels of the specific enzyme marker eosinophil peroxidase. These results demonstrate that eosinophil recruitment in EAE is dependent on LTB4 receptor ligation and further reveal a previously unrecognized role for eosinophils in the pathogenesis of this disease.


Subject(s)
Benzopyrans/pharmacology , Carboxylic Acids/pharmacology , Cell Movement/drug effects , Encephalomyelitis, Autoimmune, Experimental/etiology , Eosinophils/drug effects , Receptors, Leukotriene B4/antagonists & inhibitors , Amino Acid Sequence , Animals , Benzopyrans/therapeutic use , Carboxylic Acids/therapeutic use , Encephalomyelitis, Autoimmune, Experimental/pathology , Encephalomyelitis, Autoimmune, Experimental/prevention & control , Female , Immunization, Passive , Mice , Mice, Inbred Strains , Molecular Sequence Data , Oligopeptides/immunology , Paralysis/prevention & control , Spinal Cord/pathology , T-Lymphocytes/immunology
5.
Inflamm Res ; 44(4): 169-77, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7545527

ABSTRACT

Intraperitoneal injection of inflammatory agents in the mouse and rat causes plasma protein and leukocyte extravasation into the peritoneal cavity. Following an intraperitoneal injection of zymosan A, the milky spots of the omentum were the only abdominal sites detected where intravenously administered Monastral Blue labeled interendothelial cell gaps responsible for plasma extravasation. In addition, when colored microspheres were intraventricularly administered to quantify blood flow, the omentum was the only abdominal organ which showed an increase in blood flow during zymosan A peritonitis. A combination of light and electron microscopy, plus measurement of myeloperoxidase activity (a marker of neutrophil accumulation) demonstrated that the omental milky spots are the major route through which leukocytes migrate into the peritoneal cavity. Identical structures in the pleura likewise are the sites of protein leakage into the pleural cavity. In contrast, selective sites of protein and cellular extravasation could not be detected in the synovial lining of the inflamed knee joint.


Subject(s)
Blood Proteins/metabolism , Leukocytes/metabolism , Omentum/blood supply , Peritonitis/metabolism , Venules/metabolism , Animals , Arthritis/chemically induced , Arthritis/pathology , Blood Flow Velocity , Disease Models, Animal , Indoles , Male , Mice , Microscopy, Electron , Organometallic Compounds , Peritoneum/metabolism , Peritoneum/pathology , Peritonitis/chemically induced , Peritonitis/pathology , Pleurisy/chemically induced , Pleurisy/pathology , Rats , Staining and Labeling , Zymosan
6.
Rheumatol Int ; 14(5): 183-9, 1995.
Article in English | MEDLINE | ID: mdl-7724994

ABSTRACT

The effect of running activity on normal and inflamed knees was determined by light microscopic (LM) and scanning electron microscopic (SEM) observations on hamster articular cartilage. Animals were split into two groups; one housed in standard cages and one given free access to running wheels. Twenty-one days prior to analysis, half of each group was given an intra-articular injection of lipopolysaccharide (LPS) to cause an inflammation, the other half were uninjected. No remarkable changes were observed by LM in either the control running or nonrunning groups. In contrast, cartilage proteoglycan depletion, and pannus and synovial hyperplasia were equally observed in both groups of LPS-injected animals. SEM observations on the patellae from control animals found them to be free from damage to the articular cartilage. The joints of both the LPS nonrunning and running animals contained synovial hypertrophy with villus projection from the synovial lining. However, only the LPS-injected running hamsters had cartilage fraying over large areas of the articular surface, as well as areas in which the villus projections had been flattened. These results demonstrated that mechanical stress applied to a proteoglycan-depleted cartilage enhances the breakdown of the collagen matrix as judged by fibrillation, and may aggravate the inflammation by crushing the swollen synovial lining where it encroaches on the joint space.


Subject(s)
Cartilage/physiopathology , Joints/physiopathology , Synovial Membrane/physiopathology , Animals , Cartilage/ultrastructure , Cricetinae , Disease Models, Animal , Female , Image Processing, Computer-Assisted , Inflammation/chemically induced , Inflammation/physiopathology , Lipopolysaccharides/administration & dosage , Microscopy, Electron , Microscopy, Electron, Scanning , Physical Conditioning, Animal , Proteoglycans/analysis , Proteoglycans/ultrastructure , Synovial Membrane/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...